Although prostein expression was less frequent and often at markedly lower level in these tumors than in prostate cancer, the characteristic staining pattern with a distinct granular, perinuclear cytoplasmic prostein staining was always retained. This evidence concerns the gene SLC45A3 and prostate carcinoma.